Metropolitan Life Insurance Company (MetLife)’s Amalgamated Financial AMAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,098
Closed -$26.4K 110
2024
Q1
$26.4K Hold
1,098
﹤0.01% 1726
2023
Q4
$29.6K Hold
1,098
﹤0.01% 1730
2023
Q3
$18.9K Hold
1,098
﹤0.01% 1927
2023
Q2
$17.7K Hold
1,098
﹤0.01% 1999
2023
Q1
$19.4K Hold
1,098
﹤0.01% 1898
2022
Q4
$25.3K Buy
1,098
+236
+27% +$5.72K ﹤0.01% 1876
2022
Q3
$19.4K Hold
862
﹤0.01% 2044
2022
Q2
$17.1K Hold
862
﹤0.01% 2120
2022
Q1
$15.5K Buy
+862
New +$14.7K ﹤0.01% 2199
2020
Q1
Sell
-4,895
Closed -$95.2K 2506
2019
Q4
$95.2K Buy
+4,895
New +$90.2K ﹤0.01% 2364
2019
Q3
Sell
-1,118
Closed -$19.5K 2574
2019
Q2
$19.5K Buy
+1,118
New +$18.7K ﹤0.01% 2610
2019
Q1
Sell
-4,402
Closed -$85.8K 2551
2018
Q4
$85.8K Buy
+4,402
New +$86.4K ﹤0.01% 2354

Other funds holding AMAL

Metropolitan Life Insurance Company (MetLife)'s AMAL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Amalgamated Financial (AMAL) in Q2 2024, closing a stake of 1,098 shares — an estimated $26.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMAL in Q4 2018 and held it in 12 quarters. The position peaked at $95.2K in Q4 2019. 154 funds tracked by Wall St. Rank hold AMAL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Amalgamated Financial position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,098 Amalgamated Financial shares in Q2 2024, an estimated $26.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Amalgamated Financial in Q4 2018 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Amalgamated Financial position peaked at $95.2K in Q4 2019.
  • 154 funds tracked by Wall St. Rank held Amalgamated Financial as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.